Filing Details

Accession Number:
0000950170-24-026610
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 20:00:17
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 20:00:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
70318 Tenet Healthcare Corp THC Services-General Medical & Surgical Hospitals, Nec (8062) 952557091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1852128 W Thomas Arnst 14201 Dallas Parkway
Dallas TX 75254
Evp, Chief Admin. Officer & Gc No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-03-01 5,597 $0.00 27,351 No 4 M Direct
Common Stock Disposition 2024-03-01 2,203 $94.29 25,148 No 4 F Direct
Common Stock Disposition 2024-03-01 3,976 $94.03 21,172 No 4 S Direct
Common Stock Disposition 2024-03-01 9,925 $94.96 11,247 No 4 S Direct
Common Stock Disposition 2024-03-01 3,099 $95.48 8,148 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 2023 March Restricted Stock Units Acquisiton 2024-03-01 5,597 $0.00 5,597 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,196 No 4 M Direct
Footnotes
  1. The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on March 1, 2023, vest equally in 1/3 increments on the first, second and third anniversaries of the grant date, and the first 1/3 increment vested on March 1, 2024.
  2. Restricted stock units convert into common stock on a one-for-one basis.
  3. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
  4. Represents the closing price of the common stock of the Issuer on March 1, 2024.
  5. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $93.395 to $94.39. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  6. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $94.395 to $95.37. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  7. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $95.40 to $95.62. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.